United States - English - NLM (National Library of Medicine)

major pharmaceuticals - famotidine (unii: 5qzo15j2z8) (famotidine - unii:5qzo15j2z8) - famotidine 20 mg - acid reducer

United States - English - NLM (National Library of Medicine)

major pharmaceuticals - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - pain reliever/fever reducer

United States - English - NLM (National Library of Medicine)

major pharmaceuticals - chlorhexidine gluconate (unii: mor84mud8e) (chlorhexidine - unii:r4ko0dy52l) - chlorhexidine gluconate oral rinse should not be used by persons who are known to be hypersensitive to chlorhexidine gluconate or other formula ingredients. clinical effectiveness and safey of chlorhexidine gluconate oral rinse have not been established in children under the age of 18.

United States - English - NLM (National Library of Medicine)

major pharmaceuticals - calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb) - calcium carbonate 500 mg - antacid relieves: • heartburn • sour stomach • acid indigestion • upset stomach associated with these symptoms

United States - English - NLM (National Library of Medicine)

major pharmaceuticals - mineral oil (unii: t5l8t28fgp) (mineral oil - unii:t5l8t28fgp), petrolatum (unii: 4t6h12bn9u) (petrolatum - unii:4t6h12bn9u) - mineral oil 150 mg in 1 g - uses - for the temporary relief of burning, irritation, and discomfort due to dryness of the eye or exposure to wind or sun - may be used as a protectant against further irritation directions - wash your hands. - pull down the lower lid of the affected eye(s) and gently apply a small amount (1/4") of ointment to the inside of the eyelid, every 3-4 hours or as directed by a doctor.

United States - English - NLM (National Library of Medicine)

major pharmaceuticals - coal tar (unii: r533eso2ec) (coal tar - unii:r533eso2ec) - anti-dandruff controls the symptom of:

United States - English - NLM (National Library of Medicine)

major pharmaceuticals - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i) - first aid antibiotic first aid to help prevent infection in - minor cuts - scrapes - burns - in eyes - over large areas of the body - if you are allergic to any of the ingredients, due to the possiblity of anaphylactic shock - longer than 1 week unless directed by a doctor in care of deep puncture wounds, animal bites, or serious burns. - before use in case of deep puncture wounds, animal bites or serious burns - the condition persists or gets worse - a rash or allergic reaction develops

United States - English - NLM (National Library of Medicine)

major pharmaceuticals - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - first aid antibiotic first aid antibiotic first aid antibiotic first aid to help prevent infection in - minor cuts - scrapes - burns deep or puncture wounds animal bites serious burns - in eyes - over large areas of the body - if you are allergic to any of the ingredients - if you need to use longer than 1 week - the condition persists or gets worse - a rash or allergic reaction develops

United States - English - NLM (National Library of Medicine)

major pharmaceuticals - venlafaxine hydrochloride (unii: 7d7rx5a8mo) (venlafaxine - unii:grz5rcb1qg) - venlafaxine 37.5 mg - major depressive disorder venlafaxine hydrochloride extended-release capsules are indicated for the treatment of major depressive disorder. the efficacy of venlafaxine hydrochloride extended-release capsules in the treatment of major depressive disorder was established in 8- and 12-week controlled trials of adult outpatients whose diagnoses corresponded most closely to the dsm-iii-r or dsm-iv category of major depressive disorder (see clinical trials ). a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed mood or the loss of interest or pleasure in nearly all activities, representing a change from previous functioning, and includes the presence of at least five of the following nine symptoms during the same two-week period: depressed mood, markedly diminished interest or pleasure in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, fe

United States - English - NLM (National Library of Medicine)

major pharmaceuticals - oxymetazoline hydrochloride (unii: k89mj0s5vy) (oxymetazoline - unii:8vln5b44zy) - nasal decongestant symptoms persist